Effects and Complications of Bevacizumab Use in Patients with Retinopathy of Prematurity: A Multicenter Study in Taiwan
- 1 January 2011
- journal article
- research article
- Published by Elsevier in Ophthalmology
- Vol. 118 (1) , 176-183
- https://doi.org/10.1016/j.ophtha.2010.04.018
Abstract
No abstract availableKeywords
Funding Information
- National Science Council (96-2314-B-182A-094)
This publication has 46 references indexed in Scilit:
- Intravitreal Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: The Second Year of a Prospective StudyAmerican Journal of Ophthalmology, 2009
- PLASMIN ENZYME-ASSISTED VITRECTOMY FOR PRIMARY AND REOPERATED EYES WITH STAGE 5 RETINOPATHY OF PREMATURITYRetina, 2008
- Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic RetinopathyPublished by Elsevier ,2006
- Intravitreal Injection of Bevacizumab (Avastin) as Adjunctive Treatment of Proliferative Diabetic RetinopathyAmerican Journal of Ophthalmology, 2006
- INTRAVITREAL BEVACIZUMAB TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATIONRetina, 2006
- Outcome of Eyes Developing Retinal Detachment During the Early Treatment for Retinopathy of Prematurity Study (ETROP)Archives of Ophthalmology (1950), 2006
- Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2004
- Revised Indications for the Treatment of Retinopathy of PrematurityArchives of Ophthalmology (1950), 2003
- Partial Retinal Detachment at 3 Months After Threshold Retinopathy of PrematurityArchives of Ophthalmology (1950), 1996
- Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurityNature Medicine, 1995